# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Anaplastic Ependymoma

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-5 of 5 results.
LET Optimized IMPT in Treating Pediatric Patients With Ependymoma
Status: Recruiting
Last Changed: Jun 12, 2019
First Received: Nov 23, 2018
Disease(s): Anaplastic Ependymoma, Ependymoma
Intervention(s): Linear Energy Transfer-Optimized Intensity Modulated Proton Therapy, Quality-of-Life Assessment, Questionnaire Administration
Locations: Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
M D Anderson Cancer Center, Houston, Texas, United States
Carboplatin and Bevacizumab for Recurrent Ependymoma
Status: Recruiting
Last Changed: Jan 13, 2020
First Received: Feb 15, 2011
Disease(s): Ependymoma, Anaplastic Ependymoma
Intervention(s): Carboplatin, Bevacizumab
Locations: Harvard Cancer Center, Boston, Massachusetts, United States
MD Anderson Cancer Center, Houston, Texas, United States
Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma
Status: Recruiting
Last Changed: Mar 25, 2020
First Received: Nov 01, 2018
Disease(s): Anaplastic Ependymoma, Ependymoma, Ependymomas
Intervention(s): Marizomib
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
Status: Recruiting
Last Changed: Feb 05, 2019
First Received: Mar 30, 2016
Disease(s): Glioblastoma Multiforme, Astrocytoma, Grade III, Anaplastic Ependymoma, Clear Cell Ependymoma, Ependymoma
Intervention(s): Heat Shock Protein Peptide Complex-96 (HSPPC-96), Tumor Resection, Radiation
Locations: Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
Status: Recruiting
Last Changed: Feb 18, 2020
First Received: Feb 15, 2018
Disease(s): Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Ganglioglioma, Anaplastic Meningioma, Anaplastic Oligodendroglioma, Pleomorphic Xanthoastrocytoma, Anaplastic, Atypical Teratoid/Rhabdoid Tumor, Brain Cancer, Brain Tumor, Central Nervous System Neoplasms, Choroid Plexus Carcinoma, CNS Embryonal Tumor With Rhabdoid Features, Ganglioneuroblastoma of Central Nervous System, CNS Tumor, Embryonal Tumor of CNS, Ependymoma, Glioblastoma, Glioma, Glioma, Malignant, Medulloblastoma, Medulloblastoma; Unspecified Site, Medulloepithelioma, Neuroepithelial Tumor, Neoplasms, Neoplasms, Neuroepithelial, Papillary Tumor of the Pineal Region (High-grade Only), Pediatric Brain Tumor, Pineal Parenchymal Tumor of Intermediate Differentiation (High-grade Only), Pineoblastoma, Primitive Neuroectodermal Tumor, Recurrent Medulloblastoma, Refractory Brain Tumor, Neuroblastoma. CNS, Glioblastoma, IDH-mutant, Glioblastoma, IDH-wildtype, Medulloblastoma, Group 3, Medulloblastoma, Group 4, Glioma, High Grade, Neuroepithelial Tumor, High Grade, Medulloblastoma, SHH-activated and TP53 Mutant, Medulloblastoma, SHH-activated and TP53 Wildtype, Medulloblastoma, Chromosome 9q Loss, Medulloblastoma, Non-WNT Non-SHH, NOS, Medulloblastoma, Non-WNT/Non-SHH, Medulloblastoma, PTCH1 Mutation, Medulloblastoma, WNT-activated, Ependymoma, Recurrent, Glioma, Recurrent High Grade, Glioma, Recurrent Malignant, Embryonal Tumor, NOS, Glioma, Diffuse Midline, H3K27M-mutant, Embryonal Tumor With Multilayered Rosettes (ETMR), Ependymoma, NOS, WHO Grade III, Ependymoma, NOS, WHO Grade II, Medulloblastoma, G3/G4, Ependymoma, RELA Fusion Positive
Intervention(s): Gemcitabine, ribociclib, sonidegib, trametinib, filgrastim
Locations: St. Jude Children's Research Hospital, Memphis, Tennessee, United States